Canada Life Assurance Adds $12M in DuPont de Nemours, Inc. ($DD)
Canada Life Assurance boosted its investment in DuPont by 19%, adding 87,216 shares.
Key Points
- Canada Life Assurance boosted its DuPont position by 19%, adding 87,216 shares for a total of 545,649 shares valued at $76.4 million as of the latest SEC filing.
- DuPont shares traded near $140.01 on Wednesday with a market cap of $19.5 billion and a P/E ratio of 126.8.
- Insiders at DuPont, including CEO Lori Koch, sold shares recently, while analysts maintain mixed ratings with targets ranging from $47 to $156.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Canada Life Assurance boosted its investment in DuPont de Nemours, Inc. (NYSE: DD), adding 87,216 shares. This increase brings its total holdings to 545,649 shares, valued at about $76.4 million, according to the latest Form 13F filing with the SEC. This move represents a 19% increase in their stake during the reporting period.
Canada Life Assurance vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in Canada Life Assurance's DuPont Position
Canada Life Assurance increased its stake in DuPont by 19%, adding 87,216 shares to its portfolio. This brings its total holdings to 545,649 shares, worth approximately $76.4 million. Previously, the fund held 458,433 shares.
Other Institutional Activity in DuPont
Several other institutional investors also made adjustments to their DuPont holdings. BlackRock, Inc. grew its holdings by 116,637 shares, ending with 10,387,631 shares valued at roughly $1.43 billion, a 1.1% increase. Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both opened new positions, with 8,864,631 shares valued at $1.22 billion and 6,434,770 shares valued at $884.1 million, respectively. State Street Corp added 97,151 shares, bringing its total to 6,234,508 shares worth about $856.6 million, marking a 1.6% increase. Conversely, Invesco Ltd. reduced its position by 863,149 shares, holding 3,975,051 shares valued at $546.2 million, a 17.8% decrease.
DuPont de Nemours, Inc. Stock Down 0.5%
Shares of DuPont de Nemours, Inc. traded near $140.01 on Wednesday. The company has a market cap of $19.5 billion, with a P/E ratio of 126.8 and a forward P/E of 18.4. DuPont's stock has seen a 52-week low of $27.45 and a high of $52.66. Its 50-day moving average is $47.62, while the 200-day moving average stands at $42.31. The company maintains a current ratio of 2.68 and a quick ratio of 1.08, with a debt-to-equity ratio of 22.59.
$DD stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
DuPont reported revenue of approximately $6.92 billion, growing by 4.3% year-over-year. The company's earnings per share (EPS) stood at $0.38, with a net margin of -0.42% and a return on equity of 0.9%. The next earnings report is scheduled for August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
1 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 10.4%. Revenue missed estimates by 2.0%.
-
Profit surprise
EBITDA missed by 46 percent. Operating income missed by 52 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
1 target raise.
-
Earnings quality
Gross margin up 3.2 points. Operating margin down 5.0 points. Positive free cash flow.
Earnings Call Summary
DuPont delivered a strong first quarter with organic sales growth of 2 percent and 20 percent adjusted earnings growth on a pro forma basis. Healthcare sales were especially strong at high single digit growth, while water was hampered by about $10 million in shipment delays from Middle East logistics disruptions. Management emphasized continued innovation, with plans to launch an AI platform for product development, and noted steady progress on their operational improvement program including Kaizen events. The company completed the Aramids divestiture and announced a $275 million accelerated share buyback, returning capital to shareholders while maintaining balance sheet strength.
Guidance DuPont raised full year sales guidance to about $7.2 billion and adjusted earnings to $2.35 to $2.40 per share. They expect about 4 percent organic growth for the year, including roughly 1 percent from pricing to cover higher raw material costs from the Middle East conflict. The company also projects strong margin expansion through the rest of the year.
Neutral report. Results and guidance were close to expectations, with limited evidence of a reset either way.
Dividend
DuPont pays an annual dividend rate of $0.80, yielding 1.68%. The dividend payout ratio is 3.21%.
Insider Buying and Selling at DuPont de Nemours, Inc.
Recent insider transactions at DuPont include CEO Lori Koch selling 261 shares at $48.82 on June 2, 2026. Additionally, SVP & CFO Antonella Franzen sold 1,558 shares at $48.03 on May 31, 2026, while Lori Koch sold another 4,673 shares on the same day. On the buying side, Alexander Cutler, Frederick Lowery, and Donald Macpherson purchased a total of 2,504 shares at $48.42 on May 29, 2026.
Analysts Set New Price Targets
On June 23, 2026, Morgan Stanley maintained a hold rating on DuPont with a price target of $156. UBS maintained its buy rating with a target of $59 on May 6, 2026. RBC Capital and Citigroup also maintained buy ratings with targets of $56, while B of A Securities kept a hold rating with a target of $47. The consensus among 16 analysts is a buy recommendation, with an average target price of $56.81.
About DuPont de Nemours
DuPont de Nemours, Inc. is a global provider of technology-based materials and solutions, operating through its Healthcare & Water Technologies and Diversified Industrials segments. Headquartered in Wilmington, Delaware, the company serves a wide range of industries including healthcare, water filtration, and construction. DuPont's well-known products include TYVEK protective suits, STYROFOAM insulation, and CORIAN solid surfaces. Lori D. Koch leads the company as CEO, with a workforce of around 15,000 employees.
Bottom Line
Canada Life Assurance's decision to increase its stake in DuPont reflects a notable increase in confidence in the company's potential. As a major player in the specialty chemicals industry, DuPont continues to attract institutional interest. Investors often track these filings for insights, though it's important to remember that 13F filings are historical and may not reflect current positions.
Get DuPont de Nemours, Inc. alerts
New 13F filings, insider trades, and analyst moves on $DD, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.